GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Pharmacology and Therapeutics

Volumn 138, Issue 2, 2013, Pages 155-175

  Allen, Shelley J ^a   Watson, Judy J ^a   Shoemark, Deborah K ^a   Barua, Neil U ^b   Patel, Nikunj K ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's; BDNF; GDNF; NGF; Parkinson's; Trk

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; EARLY GROWTH RESPONSE FACTOR 1; GALANTAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOSAMINOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; LEVODOPA; MEMANTINE; MESSENGER RNA; NEUROTROPHIN RECEPTOR P75; NEURTURIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RET; RIVASTIGMINE; SORTILIN; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; BRADYKINESIA; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; DOWN SYNDROME; GENE MUTATION; GENE THERAPY; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; INFUSION; LONG TERM DEPRESSION; MENTAL DISEASE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NERVE DEGENERATION; NONHUMAN; PALLIDOTOMY; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PHASE 1 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PURKINJE CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETT SYNDROME; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; TRISOMY 21;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; LIGANDS; MODELS, MOLECULAR; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES;

EID: 84875224517     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.01.004     Document Type: Review

References (252)

1. Y. Ai, W. Markesbery, Z. Zhang, R. Grondin, D. Elseberry, and G.A. Gerhardt Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects J Comp Neurol 461 2003 250 261
2. M.S. Airaksinen, and M. Saarma The GDNF family: signalling, biological functions and therapeutic value Nat Rev Neurosci 3 2002 383 394
3. S.J. Allen, D. Dawbarn, M.G. Spillantini, M. Goedert, G.K. Wilcock, and T.H. Moss Distribution of beta-nerve growth factor receptors in the human basal forebrain J Comp Neurol 289 1989 626 640
4. S.J. Allen, D. Dawbarn, S.H. MacGowan, G.K. Wilcock, T.H. Moss, and J.J. Semenenko A quantitative morphometric analysis of basal forebrain neurons expressing NGF receptors in normal and Alzheimer's disease brains Dementia 1 1990 125 137
5. S.J. Allen, S.H. MacGowan, J.J. Treanor, R. Feeney, G.K. Wilcock, and D. Dawbarn Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus Neurosci Lett 131 1991 135 139
6. S.J. Allen, G.K. Wilcock, and D. Dawbarn Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease Biochem Biophys Res Commun 264 1999 648 651
7. C.A. Altar, and C. Bakhit Receptor-mediated transport of human recombinant nerve growth factor from olfactory bulb to forebrain cholinergic nuclei Brain Res 541 1991 82 88
8. C.A. Altar, and P.S. DiStefano Neurotrophin trafficking by anterograde transport Trends Neurosci 2 1998 433 437
9. 125I]NT-3 Eur J Neurosci 1 1994 1389 1405
10. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2 Nat Genet 23 1999 185 188
11. R. Andero, S.A. Heldt, K. Ye, X. Liu, A. Armario, and K.J. Ressler Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning Am J Psychiatry 168 2011 163 172
12. R. Andero, N. Daviu, R.M. Escorihuela, R. Nadal, and A. Armario 7,8-Dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats Hippocampus 22 2012 399 408
13. S. Ando, S. Kobayashi, H. Waki, K. Kon, F. Fukui, and T. Tadenuma Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine J Neurosci Res 70 2002 519 527
14. S.H. Appel A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease Ann Neurol 10 1981 499 505
15. S. Arancibia, M. Silhol, F. Mouliere, J. Meffre, I. Höllinger, and T. Maurice Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats Neurobiol Dis 31 2008 316 326
16. E. Arenas, M. Trupp, P. Akerud, and C.F. Ibanez GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo Neuron 15 1995 1465 1473
17. A.E. Autry, and L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol Rev 64 2012 238 258
18. S. Balaratnasingam, and A. Janca Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders Pharmacol Ther 134 2012 116 124
19. M.J. Banfield, R.L. Naylor, A.G. Robertson, S.J. Allen, D. Dawbarn, and R.L. Brady Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5 Structure 9 2001 1191 1199
20. Y.A. Barde, D. Edgar, and H. Thoenen Purification of a new neurotrophic factor from mammalian brain EMBO J 1 1982 549 553
21. M.W. Barnett, C.E. Fisher, G. Perona-Wright, and J.A. Davies Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan J Cell Sci 115 2002 4495 4503
22. BDNF Study Group A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III) Neurology 52 1999 1427 1433
23. M. Beck, P. Flachenecker, T. Magnus, R. Giess, K. Reiners, and K.V. Toyka Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF Amyotroph Lateral Scler Other Motor Neuron Disord 6 2005 100 103
24. C. Bendotti, and M.C. Carrì Lessons from models of SOD1-linked familial ALS Trends Mol Med 10 2004 393 400
25. L.R. Berkemeier, J.W. Winslow, D.R. Kaplan, K. Nikolics, D.V. Goeddel, and A. Rosenthal Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB Neuron 7 1991 857 866
26. A. Bienemann, E. White, M. Woolley, E. Castrique, D.E. Johnson, and M. Wyatt The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery J Neurosci Methods 203 2011 284 291
27. K.M. Bishop, E.K. Hofer, A. Mehta, A. Ramirez, L. Sun, and M. Tuszynski Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons Exp Neurol 211 2008 574 584
28. A. Blesch, J.M. Conner, and M.H. Tuszynski Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression Gene Ther 8 2001 954 960
29. A. Blochl, and R. Blochl A cell-biological model of p75NTR signaling J Neurochem 102 2007 289 305
30. V. Bonifati Genetics of Parkinson's disease Minerva Med 96 2005 175 186
31. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, and T. Ratovitsky Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
32. D.M. Bowen, C.B. Smith, P. White, and A.N. Davison Neurotransmitter- related enzymes and indices of hypoxia in senile dementia and other abiotrophies Brain 99 1976 459 496
33. K.E. Bowenkamp, P.A. Lapchak, B.J. Hoffer, P.J. Miller, and P.C. Bickford Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats Exp Neurol 145 1997 104 117
34. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
35. A. Buj-Bello, V.L. Buchman, A. Horton, A. Rosenthal, and A.M. Davies GDNF is an age-specific survival factor for sensory and autonomic neurons Neuron 15 1995 821 828
36. J.M. Canals, J.R. Pineda, J.F. Torres-Peraza, M. Bosch, R. Martin-Ibanez, and M.T. Munoz Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease J Neurosci 24 2004 7727 7739
37. S. Capsoni, G. Ugolini, A. Comparini, F. Ruberti, N. Berardi, and A. Cattaneo Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice Proc Natl Acad Sci U S A 97 2000 6826 6831
38. S. Capsoni, S. Giannotta, and A. Cattaneo Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice Proc Natl Acad Sci U S A 99 2002 12432 12437
39. S. Capsoni, C. Tiveron, D. Vignone, G. Amato, and A. Cattaneo Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration Proc Natl Acad Sci U S A 107 2010 12299 12304
40. S. Capsoni, S. Marinelli, M. Ceci, D. Vignone, G. Amato, and F. Malerba Intranasal "painless" human Nerve Growth Factors slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice PLoS One 7 2012 e37555
41. B.J. Carter, P. Anklesaria, S. Choi, and J.F. Engelhardt Redox modifier genes and pathways in amyotrophic lateral sclerosis Antioxid Redox Signal 11 2009 1569 1586
42. E. Castren, V. Voikar, and T. Rantamaki Role of neurotrophic factors in depression Curr Opin Pharmacol 7 2007 18 21
43. Q. Chang, G. Khare, V. Dani, S. Nelson, and R. Jaenisch The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression Neuron 49 2006 341 348
44. M.V. Chao The p75 neurotrophin receptor J Neurobiol 25 1994 1373 1385
45. M.V. Chao, and B.L. Hempstead p75 and Trk: a two-receptor system Trends Neurosci 18 1995 321 326
46. M.V. Chao, R. Rajagopal, and F.S. Lee Neurotrophin signalling in health and disease Clin Sci 110 2006 167 173
47. K.S. Chen, M.C. Nishimura, M.P. Armanini, C. Crowley, S.D. Spencer, and H.S. Phillips Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits J Neurosci 17 1997 7288 7296
48. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psychiatry 50 2001 260 265
49. Z. Chen, Y. Chai, L. Cao, A. Huang, R. Cui, and C. Lu Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway respectively in PC12 cells Neuroscience 10 2001 593 598
50. S. Cohen, R. Levi-Montalcini, and V. Hamburger A nerve growth-stimulating factor isolated from sarcomas 37 and 180 Proc Natl Acad Sci U S A 40 1954 1014 1018
51. B. Connor, D. Young, Q. Yan, R.L. Faull, B. Synek, and M. Dragunow Brain-derived neurotrophic factor is reduced in Alzheimer's disease Brain Res Mol Brain Res 49 1997 71 81
52. 125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats Neuroscience 62 1994 625 629
53. J.D. Cooper, A. Salehi, J.D. Delcroix, C.L. Howe, P.V. Belichenko, and J. Chua-Couzens Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion Proc Natl Acad Sci U S A 98 2001 10439 10444
54. J.C. Corona, L.B. Tovar-y-Romo, and R. Tapia Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis Expert Opin Ther Targets 11 2007 1415 1428
55. S. Costa, M.M. Iravani, R.K. Pearce, and P. Jenner Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets Eur J Pharmacol 412 2001 45 50
56. E.J. Coulson, K. Reid, K.M. Shipham, S. Morley, T.J. Kilpatrick, and P.F. Bartlett The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling Prog Brain Res 146 2004 41 62
57. P.E. Cramer, J.R. Cirrito, D.W. Wesson, C.Y. Lee, C. Karlo, and A.E. Zinn ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models Science 335 2012 1503 1506
58. C. Crowley, S.D. Spencer, M.C. Nishimura, K.S. Chen, S. Pitts-Meek, and M.P. Armanini Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons Cell 76 1994 1001 1011
59. K.A. Crutcher, S.A. Scott, S. Liang, W.V. Everson, and J. Weingartner Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease J Neurosci 13 1993 2540 2550
60. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
61. D. Dawbarn, S.J. Allen, and F.M. Semenenko Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain Neurosci Lett 94 1988 138 144
62. P.A. Day-Lollini, G.R. Stewart, M.J. Taylor, R.M. Johnson, and G.J. Chellman Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor Exp Neurol 145 1997 24 37
63. M. Decrassec, A. Ulusoy, B. Mattsson, B. Georgievska, M. Romero-Ramos, and D. Kirik GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's Disease Brain 134 2011 2302 2311
64. L. Devi, and M. Ohno 7,8-Dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease Neuropsychopharmacology 37 2012 434 444
65. K.M. Doherty, B.P. van de Warrenburg, M.C. Peralta, L. Silveira-Moriyama, J.P. Azulay, and O.S. Gershanik Postural deformities in Parkinson's disease Lancet Neurol 10 2011 538 549
66. W. Duan, Q. Peng, N. Masuda, E. Ford, E. Tryggestad, and B. Ladenheim Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease Neurobiol Dis 30 2008 312 322
67. L. Dupuis, M. Pehar, P. Cassina, F. Rene, R. Castellanos, and C. Rouaux Nogo receptor antagonizes p75NTR-dependent motor neuron death PNAS 105 2008 740 745
68. P. Durbec, C.V. Marcos-Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, and P. Suvanto GDNF signalling through the Ret receptor tyrosine kinase Nature 381 1996 789 793
69. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, and A. Bertolino The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
70. M. Encinas, M.G. Tansey, B.A. Tsui-Pierchala, J.X. Comella, J. Milbrandt, and E.M. Johnson Jr. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway J Neurosci 21 2001 1464 1472
71. J.M. Eriksdotter, A. Nordberg, K. Amberla, L. Backman, T. Ebendal, and B. Meyerson Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease Dement Geriatr Cogn Disord 9 1998 246 257
72. A.M. Fagan, M. Garber, M. Barbacid, I. Silos-Santiago, and D.M. Holtzman A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo J Neurosci 17 1997 7644 7654
73. M. Fahnestock, B. Michalski, B. Xu, and M.D. Coughlin The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease Mol Cell Neurosci 18 2001 210 220
74. D.S. Falconer Wobbler (Wr) Mouse News Lett 15 1956 23 29
75. G. Favalli, J. Li, P. Belmonte-de-Abreu, A.H. Wong, and Z.J. Daskalakis The role of BDNF in the pathophysiology and treatment of schizophrenia J Psychiatr Res 46 2012 1 11
76. I. Ferrer, C. Marin, M.J. Rey, T. Ribalta, E. Goutan, and R. Blanco BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies J Neuropathol Exp Neurol 58 1999 729 739
77. I. Ferrer, E. Goutan, C. Marin, M.J. Rey, and T. Ribalta Brain-derived neurotrophic factor in Huntington disease Brain Res 866 2000 257 261
78. W. Fischer, K. Wictorin, A. Bjorklund, L.R. Williams, S. Varon, and F.H. Gage Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor Nature 329 1987 65 68
79. A.M. Fletcher, T.H. Kowalczyk, L. Padegimas, M.J. Cooper, and D.M. Yurek Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor Neuroscience 194 2011 220 226
80. F. Fumagalli, G. Racagni, and M.A. Riva Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease Pharmacogenomics J 6 2006 95 104
81. B. Gabriele, and E. Tongiorgi BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress J Cell Sci 122 2009 36 43
82. C.M. Gall, S.J. Gold, P.J. Isackson, and K.B. Seroogy Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons Mol Cell Neurosci 3 1992 56 63
83. E. Garbayo, C.N. Montero-Menei, E. Ansorena, J.L. Lanciego, M.S. Aymerich, and M.J. Blanco-Prieto Effective GDNF brain delivery using microspheres - a promising strategy for Parkinson's Disease J Control Release 135 2009 119 126
84. E. Garbayo, E. Ansorena, J.L. Lanciego, M.J. Blanco-Prieto, and M.S. Aymeric Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's Disease Mov Disord 26 2011 1943 1947
85. L.R. Gauthier, C.C. Charrin, M. Borrell-Pagès, J.P. Dompierre, H. Rangone, and F.P. Cordelières Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138
86. G.A. Gerhardt, W.A. Cass, P. Huettl, S. Brock, Z. Zhang, and D.M. Gash GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys Brain Res 817 1999 163 171
87. K. Gharami, Y. Xie, J.J. An, S. Tonegawa, and B. Xu Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice J Neurochem 2 2008 369 379
88. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, and M. Bunnage Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat Med 9 2003 589 595
89. Y. Gimenez, M. Ribotta, F. Revah, L. Pradier, I. Loquet, and J. Mallet Prevention of motoneuron death by adenovirus-mediated neurotrophic factors J Neurosci Res 48 1997 281 285
90. F. Gimenez, M.T. Krauze, F. Valles, P. Hadaczek, J. Bringas, and N. Sharma Image-guided convection-enhanced delivery of GDNF protein into monkey putamen Neuroimage 54 2011 S189 S195
91. A. Giralt, T. Rodrigo, E.D. Martin, J.R. Gonzalez, M. Mila, and V. Cena Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression Neuroscience 158 2009 1234 1250
92. A. Giralt, H.C. Friedman, B. Caneda-Ferron, N. Urban, E. Moreno, and N. Rubio BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease Gene Ther 17 2010 1294 1308
93. A. Giralt, O. Carretón, C. Lao-Peregrin, E.D. Martín, and J. Alberch Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction Mol Neurodegener 6 2011 71 (1-16)
94. A. Goate, and J. Hardy Twenty years of Alzheimer's disease-causing mutations J Neurochem 120 Suppl. 1 2012 3 8
95. L. Grandoso, S. Ponce, I. Manuel, A. Arrúe, J.A. Ruiz-Ortega, and I. Ulibarri Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats Int J Pharm 343 2007 69 78
96. G.A. Graveland, R.S. Williams, and M. Difiglia Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease Science 227 1985 770 773
97. R. Grondin, Z. Zhang, A. Yi, W.A. Cass, N. Maswood, and A.H. Andersen Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys Brain 125 2002 2191 2201
98. R. Grondin, W.A. Cass, Z. Zhang, J.A. Stanford, D.M. Gash, and G.A. Gerhardt Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys J Neurosci 23 2003 1974 1980
99. E. Grundström, D. Lindholm, A. Johansson, K. Blennow, and H. Askmark GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis Neuroreport 11 2000 1781 1783
100. H.J. Gruss, and S.K. Dower The TNF ligand superfamily and its relevance for human diseases Cytokines Mol Ther 1 1995 75 105
101. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, and D.D. Alexander Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775
102. B. Hagberg, J. Aicardi, K. Dias, and O. Ramos A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases Ann Neurol 14 1983 471 479
103. A.M. Hall, R.Y. Moore, O.L. Lopez, L. Kuller, and J.T. Becker Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease Alzheimers Dement 4 2008 271 279
104. F. Hallböök, C.F. Ibáñez, and H. Persson Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary Neuron 6 1991 845 858
105. J. Hardy A hundred years of Alzheimer's disease research Neuron 52 2006 3 13
106. J. Hardy, and D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol Sci 12 1991 383 388
107. E.C. Hirsch Animal models in neurodegenerative diseases J Neural Transm Suppl 72 2007 87 90
108. C. Hock, K. Heese, C. Hulette, C. Rosenberg, and U. Otten Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas Arch Neurol 57 2000 846 851
109. R.M. Holsinger, J. Schnarr, P. Henry, V.T. Castelo, and M. Fahnestock Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease Brain Res Mol Brain Res 76 2000 347 354
110. D.N. Hovland Jr., R.B. Boyd, M.T. Butt, J.A. Engelhardt, M.S. Moxness, and M.H. Ma Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys Toxicol Pathol 35 2007 1013 1029
111. D.W. Howells, M.J. Porritt, J.Y. Wong, P.E. Batchelor, R. Kalnins, and A.J. Hughes Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp Neurol 166 2000 127 135
112. D.R. Howlett APP transgenic mice and their application to drug discovery Histol Histopathol 26 2011 1611 1632
113. E.J. Huang, and L.F. Reichardt Neurotrophins: roles in neuronal development and function Annu Rev Neurosci 24 2001 677 736
114. C. Hyman, M. Hofer, Y.A. Barde, M. Juhasz, G.D. Yancopoulos, and S.P. Squinto BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 1991 230 232
115. K. Ikeda, B. Klinkosz, T. Greene, J.M. Cedarbaum, V. Wong, and R.M. Lindsay Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease Ann Neurol 37 1995 505 511
116. M.M. Iravani, S. Costa, M.J. Jackson, B.C. Tel, C. Cannizzaro, and R.K. Pearce GDNF reverses priming for dyskinesia in MPTP-treated, l-DOPA-primed common marmosets Eur J Neurosci 13 2001 597 608
117. S.W. Jang, M. Okada, I. Sayeed, G. Xiao, D. Stein, and P. Jin Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death Proc Natl Acad Sci U S A 104 2007 16329 16334
118. S.W. Jang, X. Liu, M. Yepes, K.R. Shepherd, G.W. Miller, and Y. Liu A selective TrkB agonist with potent neurotrophicactivities by 7,8-dihydroxyflavone Proc Natl Acad Sci U S A 107 2010 2687 2692
119. R.A. Johnson, M. Lam, A.M. Punzo, H. Li, B.R. Lin, and K. Ye 7,8-Dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome J Appl Physiol 112 2012 704 710
120. L.C. Johnston, J. Eberling, P. Pivirotto, P. Hadaczek, H.J. Federoff, and J. Forsayeth Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys Hum Gene Ther 20 2009 497 510
121. S. Kalra, A. Genge, and D.L. Arnold A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results Amyotroph Lateral Scler Other Motor Neuron Disord 4 2003 22 26
122. C.M. Kearns, W.A. Cass, K. Smoot, R. Kryscio, and D.M. Gash GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis J Neurosci 17 1997 7111 7118
123. A.P. Kells, J. Eberling, X. Su, P. Pivirotto, J. Bringas, and P. Hadaczek Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF J Neurosci 30 2010 9567 9577
124. M.C. Kiernan, S. Vucic, B.C. Cheah, M.R. Turner, A. Eisen, and O. Hardiman Amyotrophic lateral sclerosis Lancet 377 2011 942 955
125. D. Kirik, C. Rosenblad, and A. Bjorklund Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor Eur J Neurosci 12 2000 3871 3882
126. D. Kirik, B. Georgievska, C. Rosenblad, and A. Bjorklund Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease Eur J Neurosci 13 2001 1589 1599
127. R.L. Klein, M.H. Lewis, N. Muzyczka, and E.M. Meyer Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer Brain Res 847 1999 314 320
128. R.M. Koffie, B.T. Hyman, and T.L. Spires-Jones Alzheimer's disease: synapses gone cold Mol Neurodegener 6 2011 63
129. R. Kohno, H. Sawada, Y. Kawamoto, K. Uemura, H. Shibasaki, and S. Shimohama BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line Biochem Biophys Res Commun 318 2004 113 118
130. M. Kokaia, P. Ernfors, Z. Kokaia, E. Elmer, R. Jaenisch, and O. Lindvall Suppressed epileptogenesis in BDNF mutant mice Exp Neurol 133 1995 215 224
131. M. Korte, P. Carroll, E. Wolf, G. Brem, H. Thoenen, and T. Bonhoeffer Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor Proc Natl Acad Sci U S A 92 1995 8856 8860
132. M. Korte, O. Griesbeck, C. Gravel, P. Carroll, V. Staiger, and H. Thoenen Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice Proc Natl Acad Sci USA 93 1996 12547 12552
133. L.F. Kromer Nerve growth factor treatment after brain injury prevents neuronal death Science 235 1987 214 216
134. A.E. Lang, S. Gill, N.K. Patel, A. Lozano, J.G. Nutt, and R. Penn Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann Neurol 59 2006 459 466
135. P.A. Lapchak, S. Jiao, F. Collins, and P.J. Miller Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection Brain Res 747 1997 92 102
136. P.A. Lapchak, P.J. Miller, F. Collins, and S. Jiao Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery Neuroscience 78 1997 61 72
137. P.A. Lapchak, P.J. Miller, and S. Jiao Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats Neuroscience 77 1997 745 752
138. 125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection Brain Res 789 1998 9 22
139. D. Lappalainen, R. Lindholm, and Riikonen Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome J Child Neurol 11 1996 296 300
140. J. Leibrock, F. Lottspeich, A. Hohn, M. Hofer, B. Hengerer, and P. Masiakowski Molecular cloning and expression of brain-derived neurotrophic factor Nature 341 1989 149 152
141. R. Levi-Montalcini, and S. Cohen Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals Ann N Y Acad Sci 85 1960 324 341
142. R. Levi-Montalcini, and V. Hamburger Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo J Exp Zool 116 1951 321 361
143. T. Leyhe, E. Stransky, G.W. Eschweiler, G. Buchkremer, and C. Laske Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease Eur Arch Psychiatr Clin Neurosci 258 2008 124 128
144. W. Li, D. Brakefield, Y. Pan, D. Hunter, T.M. Myckatyn, and A. Parsadanian Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS Exp Neurol 203 2007 457 471
145. L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 21 1993 1130 1132
146. S. Love, P. Plaha, N.K. Patel, G.R. Hotton, D.J. Brooks, and S.S. Gill Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain Nat Med 11 2005 703 704
147. B. Lu, P.T. Pang, and N.H. Woo The yin and yang of neurotrophin action Nat Rev Neurosci 6 2005 603 614
148. G. Lynch, E.A. Kramar, C.S. Rex, Y. Jia, D. Chappas, and C.M. Gall Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease J Neurosci 27 2007 4424 4434
149. P.C. Maisonpierre, L. Belluscio, S. Squinto, N.Y. Ip, M.E. Furth, and R.M. Lindsay Neurotrophin-3: a neurotrophic factor related to NGF and BDNF Science 247 1990 1446 1451
150. L.A. Mamounas, M.E. Blue, J.A. Siuciak, and C.A. Altar Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain J Neurosci 15 1995 7929 7939
151. D. Martin, G. Miller, N. Fischer, D. Diz, T. Cullen, and D. Russell Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats Eur J Neurosci 8 1996 1249 1255
152. D. Martin, G. Miller, T. Cullen, N. Fischer, D. Dix, and D. Russell Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats Eur J Pharmacol 317 1996 247 256
153. D. Martin-Zanca, S.H. Hughes, and M. Barbacid A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences Nature 319 1986 743 748
154. M. Marvanova, M. Lakso, J. Pirhonen, H. Nawa, G. Wong, and E.A. Castrén The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain Mol Cell Neurosci 18 2001 247 258
155. S.M. Massa, Y. Xie, T. Yang, A.W. Harrington, M.L. Kim, and S.O. Yoon Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death J Neurosci 26 2006 5288 5300
156. S.M. Massa, T. Yang, Y. Xie, J. Shi, M. Bilgen, and J.N. Joyce Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents J Clin Invest 120 2010 1774 1785
157. N. Maswood, R. Grondin, Z. Zhang, J.A. Stanford, S.P. Surgener, and D.M. Gash Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys Neurobiol Aging 23 2001 881 889
158. T. Matsuishi, Y. Yamashita, T. Takahashi, and S. Nagamitsu Rett syndrome: the state of clinical and basic research, and future perspectives Brain Dev 33 2011 627 631
159. F. Meisner, C. Scheller, S. Kneitz, S. Sopper, E. Neuen-Jacob, and P. Riederer Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine Neuropsychopharmacology 33 2008 2228 2236
160. M. Mogi, A. Togari, T. Kondo, Y. Mizuno, O. Komure, and S. Kuno Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci Lett 270 1999 45 48
161. M.H. Mohajeri, D.A. Figlewicz, and M.C. Bohn Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis Hum Gene Ther 10 1999 1853 1866
162. E.J. Mufson, M. Bothwell, and J.H. Kordower Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain Exp Neurol 105 1989 221 232
163. E.J. Mufson, J.S. Kroin, T.J. Sendera, and T. Sobreviela Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases Prog Neurobiol 57 1999 451 484
164. P.S. Murray, and P.V. Holmes An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus Int J Peptides 2011 2011 1 12 10.1155/2011/654085
165. A.H. Nagahara, D.A. Merrill, G. Coppola, S. Tsukada, B.E. Schroeder, and G.M. Shaked Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease Nat Med 15 2009 331 337
166. P. Naveilhan, C. Baudet, A. Mikaels, L. Shen, H. Westphal, and P. Ernfors Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor Proc Natl Acad Sci U S A 95 1998 1295 1300
167. R.L. Naylor, A.G. Robertson, S.J. Allen, R.B. Sessions, A.R. Clarke, and G.G. Mason A discrete domain of the human TrkB receptor defines the binding sites for BDNF and NT-4 Biochem Biophys Res Commun 291 2002 501 507
168. Nel, A., Xia, T., Meng, H., Wang, X., Lin, S., Ji, Z., et al. (in press). Nanomaterial toxicity test ing in the 21st century: use of a predictive toxicological approach and high through-put screening. Acc Chem Res. http://dx.doi.org/10.1021/ar300022h.
169. T. Nishio, N. Sunohara, and S. Furukawa Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis Neuroreport 9 1998 1661 1665
170. J.G. Nutt, K.J. Burchiel, C.L. Comella, J. Jankovic, A.E. Lang, and E.R. Laws Jr. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD Neurology 60 2003 69 73
171. A. Nykjaer, and T.E. Willnow Sortilin: a receptor to regulate neuronal viability and function Trends Neurosci 35 2012 261 270
172. A. Nykjaer, R. Lee, K. Teng, P. Jansen, P. Madsen, and M. Nielsen Sortilin is essential for proNGF-induced neuronal cell death Nature 427 2004 843 848
173. G. Ochs, R.D. Penn, M. York, R. Giess, M. Beck, and J. Tonn A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis Amyotroph Lat Scler Other Motor Neuron Disord 1 2000 201 206
174. L. Olson, A. Nordberg, H.H. von, L. Backman, T. Ebendal, and I. Alafuzoff Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report) J Neural Transm Park Dis Dement Sect 4 1992 79 95
175. P.T. Pang, H.K. Teng, E. Zaitsev, N.T. Woo, K. Sakata, and S. Zhen Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity Science 306 2004 487 491
176. K. Parain, M.G. Murer, Q. Yan, B. Faucheux, Y. Agid, and E. Hirsch Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra Neuroreport 10 1999 557 561
177. G. Paratcha, F. Ledda, and C.F. Ibanez The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands Cell 113 2003 867 879
178. S. Park, H.T. Kim, S. Yun, I.S. Kim, J. Lee, and I.S. Lee Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice Exp Mol Med 41 2009 487 500
179. N.K. Patel, and S.S. Gill GDNF delivery for Parkinson's disease Acta Neurochir (Wien) 97 2007 135 154
180. N.K. Patel, M. Bunnage, P. Plaha, C.N. Svendsen, P. Heywood, and S.S. Gill Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study Ann Neurol 57 2005 298 302
181. M. Pehar, P. Cassina, M.R. Vargas, Y. Xie, J.S. Beckman, and S.M. Massa Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain Eur J Neurosci 24 2006 1575 1580
182. J. Peleshok, and H.U. Saragovi Functional mimetics of neurotrophins and their receptors Biochem Soc Trans 34 2006 612 617
183. S. Peng, J. Wuu, E.J. Mufson, and M. Fahnestock Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decrease, in the pre-clinical stages of Alzheimer's disease J Neurochem 93 2005 1412 1421
184. E. Perez-Navarro, A.M. Canudas, P. Akerund, J. Alberch, and E. Arenas Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease J Neurochem 75 2000 2190 2199
185. E.K. Perry, R.H. Perry, G. Blessed, and B.E. Tomlinson Necropsy evidence of central cholinergic deficits in senile dementia Lancet 1 1977 189
186. H. Peterziel, K. Unsicker, and K. Krieglstein TGFbeta induces GDNF responsiveness in neurons by recruitment of GFRalpha1 to the plasma membrane J Cell Biol 159 2002 157 167
187. H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, and J.W. Winslow BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease Neuron 7 1991 695 702
188. P. Pruunsild, A. Kazantseva, T. Aid, K. Palm, and T. Timmusk Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters Genomics 90 2007 397 406
189. J.K. Räty, H.P. Lesch, T. Wirth, and S. Ylä-Herttuala Improving safety of gene therapy Curr Drug Safety 3 2008 46 53
190. C.E. Reilly Wild-type huntingtin up-regulates BDNF transcription in Huntington's disease J Neurol 248 2001 920 922
191. A. Rett On a unusual brain atrophy syndrome in hyperammonemia in childhood (in German) Wien Med Wochenschr 116 1966 723 726
192. R. Riikonen Neurotrophic factors in the pathogenesis of Rett syndrome J Child Neurol 18 2003 693 697
193. R. Riikonen, and R. Vanhala Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome Dev Med Child Neurol 41 1999 148 152
194. M.F. Salvatore, Y. Ai, B. Fischer, A.M. Zhang, R.C. Grondin, and Z. Zhang Point source concentration of GDNF may explain failure of phase II clinical trial Exp Neurol 202 2006 497 505
195. H. Sauer, C. Rosenblad, and A. Bjorklund Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion Proc Natl Acad Sci U S A 92 1995 8935 8939
196. H. Sauer, V. Wong, and A. Bjorklund Brain-derived neurotrophic factor and neurotrophin-4/5 modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum Neuroscience 65 1995 927 933
197. D. Scarpi, D. Cirelli, C. Matrone, G. Castronovo, P. Rosini, and E.G. Occhiato Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity Cell Death Dis 3 2012 e339
198. J. Scott, M. Selby, M. Urdea, M. Quiroga, G.I. Bell, and W.J. Rutter Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor Nature 302 1983 538 540
199. M. Sendtner, B. Holtmann, R. Kolbeck, H. Thoenen, and Y.A. Barde Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section Nature 360 1992 757 759
200. K.B. Seroogy, K.H. Lundgren, T.M. Tran, K.M. Guthrie, P.J. Isackson, and C.M. Gall Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs J Comp Neurol 342 1994 321 334
201. D.A. Simmons, C.S. Rex, L. Palmer, V. Pandyarajan, V. Fedulov, and C.M. Gall Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice Proc Natl Acad Sci U S A 106 2009 4906 4911
202. N.R. Sims, D.M. Bowen, S.J. Allen, C.C. Smith, D. Neary, and D.J. Thomas Presynaptic cholinergic dysfunction in patients with dementia J Neurochem 40 1983 503 509
203. J.T. Slevin, D.M. Gash, C.D. Smith, G.A. Gerhardt, R. Kryscio, and H. Chebrolu Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal J Neurosurg 106 2007 614 620
204. R.J. Smeyne, R. Klein, A. Schnapp, L.K. Long, S. Bryant, and A. Lewin Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene Nature 368 1994 246 249
205. D.E. Smith, J. Roberts, F.H. Gage, and M.H. Tuszynski Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy Proc Natl Acad Sci U S A 96 1999 10893 10898
206. T. Sobreviela, D.O. Clary, L.F. Reichardt, M.M. Brandabur, J.H. Kordower, and E.J. Mufson TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin J Comp Neurol 350 1994 587 611
207. G. Sobue, M. Yamamoto, M. Doyu, M. Li, T. Yasuda, and T. Mitsuma Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies Neurochem Res 23 1998 821 829
208. J.P. Spencer Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance Proc Nutr Soc 67 2008 238 252
209. M.B. Spina, S.P. Squinto, J. Miller, R.M. Lindsay, and C. Hyman Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system J Neurochem 59 1992 99 106
210. K. Stahl, M.N. Mylonakou, E. Skare, M. Amiry-Moghaddam, and R. Torp Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease Brain Res 1378 2011 105 118
211. T.L. Steininger, B.H. Wainer, R. Klein, M. Barbacid, and H.C. Palfrey High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain Brain Res 612 1993 330 335
212. L. Studer, C. Spenger, and R.W. Seiler, A. Othberg, O., Lindvall, O. & Odin, P. Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon Exp Brain Res 108 1996 328 336
213. X. Su, A.P. Kells, E.J. Huang, H.S. Lee, P. Hadaczek, and J. Beyer Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys Hum Gene Ther 20 2009 1627 1640
214. A.M. Sullivan, J. Opacka-Juffry, and S.B. Blunt Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo Eur J Neurosci 10 1998 57 63
215. W.K. Summers, L.V. Majovski, G.M. Marsh, K. Tachiki, and A. Kling Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type N Engl J Med 315 1986 1241 1245
216. Y.E. Sun, and H. Wu The ups and downs of BDNF in Rett syndrome Neuron 49 2006 321 323
217. M. Sun, L. Kong, X. Wang, X.G. Lu, Q. Gao, and A.I. Geller Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease Brain Res 1052 2005 119 129
218. M. Suzuki, J. McHugh, C. Tork, B. Shelley, S.M. Klein, and P. Aebischer GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS PLoS One 2 2007 e689
219. M. Takeda Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model Hokkaido Igaku Zasshi 70 1995 829 838
220. D. Terwel, K.R. Steffensen, P.B. Verghese, M.P. Kummer, J.A. Gustafsson, and D.M. Holtzman Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis J Neurosci 31 2011 7049 7059
221. R.G. Thorne, and W.H. Frey Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations Clin Pharmacokinet 40 2001 907 946
222. L. Tian, R. Guo, X. Yue, Q. Lva, X. Yea, and Z. Wang Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats Brain Res 1440 2012 47 55
223. M. Trupp, E. Arenas, M. Fainzilber, A.S. Nilsson, B.A. Sieber, and M. Grigoriou Functional receptor for GDNF encoded by the c-ret proto-oncogene Nature 381 1996 785 789
224. M. Trupp, N. Belluardo, H. Funakoshi, and C.F. Ibanez Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS J Neurosci 17 1997 3554 3567
225. B.J. Turner, S.S. Murray, L.G. Piccenna, E.C. Lopes, T.J. Kilpatrick, and S.S. Cheema Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice J Neurosci Res 78 2004 193 199
226. M.H. Tuszynski Gene Therapy for Alzheimer's Disease - Clinical Trial Updates http://tuszynskilab.ucsd.edu/gt.php 2008
227. M.H. Tuszynski, D.E. Smith, J. Roberts, H. McKay, and E. Mufson Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition Exp Neurol 154 1998 573 582
228. M.H. Tuszynski, L. Thal, M. Pay, D.P. Salmon, U. Hs, and R. Bakay A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Nat Med 11 2005 551 555
229. O.B. und Halbach, L. Minichiello, and K. Unsicker Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra FASEB J 2005 10.1096/fj.05-3845fje (express article)
230. C. Wiesmann, M.H. Ultsch, S.H. Bass, and A.M. de Vos Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor Nature 401 1999 184 188
231. B. Will, and F. Hefti Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions Behav Brain Res 17 1985 17 24
232. L.R. Williams, S. Varon, G.M. Peterson, K. Wictorin, W. Fischer, and A. Bjorklund Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection Proc Natl Acad Sci U S A 83 1986 9231 9235
233. C. Winkler, H. Sauer, C.S. Lee, and A. Bjorklund Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease J Neurosci 16 1996 7206 7215
234. J. Winkler, G.A. Ramirez, H.G. Kuhn, D.A. Peterson, P.A. Day-Lollini, and G.R. Stewart Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor Ann Neurol 41 1997 82 93
235. J. Wong, D.A. Rothmond, M.J. Webster, and W.C. Shannon Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia Schizophr Bull 39 2011, Jul 27 130 140
236. N.H. Woo, H.K. Teng, C.J. Siao, C. Chiaruttini, P.T. Pang, and T.A. Milner Activation of p75NTR by proBDNF facilitates hippocampal long-term depression Nat Neurosci 8 2005 1069 1077
237. Y. Xie, M.A. Tisi, T.T. Yeo, and F.M. Longo Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects J Biol Chem 275 2000 29868 29874
238. R.Y. Xu, K. Pong, Y. Yu, D. Chang, S. Liu, and J.D. Lile Characterization of two distinct monoclonal antibodies specific for glial cell line-derived neurotrophic factor J Neurochem 70 1998 1383 1393
239. M. Yamamoto, G. Sobue, K. Yamamoto, S. Terao, and T. Mitsuma Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues Neurochem Res 21 1996 929 938
240. T. Yang, J.K. Knowles, Q. Lu, H. Zhang, O. Arancio, and L.A. Moore Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment PLoS One 3 2008 e3604
241. M. Yang, Y. Lim, X. Li, J.H. Zhong, and X.F. Zhou Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing J Biol Chem US 286 2011 16272 16284
242. E.C. Yuen, C.L. Howe, Y. Li, D.M. Holtzman, and W.C. Mobley Nerve growth factor and the neurotrophic factor hypothesis Brain Dev 18 1998 362 368
243. D.M. Yurek, A.M. Fletcher, T.H. Kowalczyk, L. Padegimas, and M.J. Cooper Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons Cell Transplant 18 2009 1183 1196
244. M.C. Zaccaro, H.B. Lee, M. Pattarawarapan, Z. Xia, A. Caron, and P.J. L'Heureux Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities Chem Biol 12 2005 1015 1028
245. Z. Zhang, Y. Miyoshi, P.A. Lapchak, F. Collins, D. Hilt, and C. Lebel Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys JPET 282 1997 1396 1401
246. C.F. Zhang, C.R. Snell, and Y.P. Loh Identification of a novel prohormone sorting signal-binding site on carboxypeptidase E, a regulated secretory pathway-sorting receptor Mol Endocrinol 13 1999 527 536
247. C. Zuccato, and E. Cattaneo Brain-derived neurotrophic factor in neurodegenerative diseases Nat Rev Neurol 5 2009 311 322
248. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, and L. Conti Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 2001 493 498
249. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, and L. Conti Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat Genet 35 2003 76 83
250. C. Zuccato, M. Marullo, P. Conforti, M.E. MacDonald, M. Tartari, and E. Cattaneo Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease Brain Pathol 18 2008 225 238
251. A.D. Zurn, E.E. Baetge, J.P. Hammang, S.A. Tan, and P. Aebischer Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones Neuroreport 30 1994 113 118
252. A.D. Zurn, L. Winkel, A. Menoud, K. Djabali, and P. Aebischer Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro J Neurosci Res 15 1996 133 141